Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Medical Information FSGS

EPPIK (Phase 2 Study): Treatment in Pediatric Patients With Proteinuric Glomerular Diseases

Medical Information FSGS

FILSPARI (sparsentan) – Acute Kidney Injury

Medical Information FSGS

FILSPARI (sparsentan) Dual Receptor Antagonism in Renal Pathophysiology and Reduction of Proteinuria

Medical Information FSGS

FILSPARI (sparsentan) – Changes in Blood Pressure and Hypotensive Events

Medical Information FSGS

FILSPARI (sparsentan) – Drug-Drug Interactions

Medical Information FSGS

FILSPARI (sparsentan) – Pharmacokinetic Profile